<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04558697</url>
  </required_header>
  <id_info>
    <org_study_id>03/7-1053/19</org_study_id>
    <nct_id>NCT04558697</nct_id>
  </id_info>
  <brief_title>Use of Vagitories Based on St. John's Wort, Tea Tree Oil and Shepherd's Purse in the Treatment of Vaginal Inflammation</brief_title>
  <official_title>Use of Vagitories Based on St. John's Wort, Tea Tree Oil and Shepherd's Purse in the Treatment of Vaginal Inflammation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sarajevo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institution for Health Protection of Women and Motherhood</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Tuzla</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sarajevo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are more and more herbal preparations that are used for the purpose of treatment and&#xD;
      improvement of the clinical picture of vaginitis by patients themselves, but also by&#xD;
      healthcare professionals. Plant species, St. John's wort, chamomile, calendula, yarrow,&#xD;
      shepherd's purse and tea tree oil are well known for there anti-inflammatory, antimicrobial&#xD;
      and wound healing activity. This paper presents the results of a clinical study in which&#xD;
      three herbal formulations/vagitories, based on extracts of above mentioned plant species,&#xD;
      were investigated for their effectiveness on non-specific vaginitis.&#xD;
&#xD;
      This was randomized controlled clinical study that included 210 women with diagnosed&#xD;
      non-specific vaginitis. Patients were divided into two basic groups, women in reproductive&#xD;
      stage and postmenopausal stage. Three subgroups, containing approximately 30 patients each,&#xD;
      received one of three vagitorie formulations for 5 days during which the effects on&#xD;
      subjective and objective symptoms were monitored.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 21, 2019</start_date>
  <completion_date type="Actual">September 30, 2019</completion_date>
  <primary_completion_date type="Actual">June 21, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in objective symptoms of non-specific vaginitis, assessed by gynecological examination</measure>
    <time_frame>1 day after treatment completion</time_frame>
    <description>The clinical symptoms and signs, including redness, hyper-secretion, local edema, pain and annealing were diagnosed at the baseline and 5 days after the beginning of the treatment. Gynecologist determined only the presence or absence of the above mentioned symptoms.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in subjective symptoms of non-specific vaginitis, assessed by the valuation of subjective parameter of vaginitis reported by patients during gynecological examination</measure>
    <time_frame>1 day after treatment completion</time_frame>
    <description>Subjective symptoms including vaginal secretion, itching and dryness of the vaginal mucous were diagnosed at the baseline and 5 days after beginning of the treatment. During anamnesis gynecologist determined the presence or absence of the above mentioned symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of vaginitis correlated with age, life habits and sexual behavior, assessed by questioner</measure>
    <time_frame>Through study completion, an average of 3 months</time_frame>
    <description>At the baseline, the patents completed a questionnaire that included questions regarding their age, life habits (permanent relationship, smoker, use of alcohol,number of births, abortion number) and sexual behavior (number of partners, years of first sexual intercourse, contraceptive use, previous presence of sexually transmitted diseases). The incidence of vaginitis correlated to above mentioned demographic data will be assessed by questioner</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">210</enrollment>
  <condition>Non Specific Vaginitis</condition>
  <arm_group>
    <arm_group_label>Shepherd's Purse extractum oleosum vagitories</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vagitories containing Calendulae extractum oleosum 5,5% (w/w), Bursae pastoris extractum oleosum 5,5% (w/w), Matricariae extractum oleosum 5,5% (w/w), Hyperici extractum oleosum 5,5% (w/w) and Millefolii extractum oleosum 5,5% (w/w) as active component</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tea tree oil vagitories</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vagitories containing tea tree oil, 200 mg per each vagitorie as active component</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyperici extractum oleosum vagitories</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vagitories containing Hyperici extractum oleosum 32% (w/w) as active component</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vagitories - Probiotic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Commercially available vagitories with probiotic</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Shepherd's Purse extractum oleosum vagitories</intervention_name>
    <description>Shepherd's Purse extractum oleosum vagitories will be administered once daily for 5 days</description>
    <arm_group_label>Shepherd's Purse extractum oleosum vagitories</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tea tree oil vagitories</intervention_name>
    <description>Tea tree oil vagitories will be administered once daily for 5 days</description>
    <arm_group_label>Tea tree oil vagitories</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hyperici extractum oleosum vagitories</intervention_name>
    <description>Hyperici extractum oleosum vagitories will be administered once daily for 5 days</description>
    <arm_group_label>Hyperici extractum oleosum vagitories</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vagitories - Probiotic</intervention_name>
    <description>Vagitories - Probiotic will be administered once daily for 5 days</description>
    <arm_group_label>Vagitories - Probiotic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adult women who already had sexual intercourse&#xD;
&#xD;
          -  diagnosis of non-specific vaginal inflammation by medical examination.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  microbiologically confirmed bacterial vaginosis,&#xD;
&#xD;
          -  treatment with antibiotic therapy according to official protocols and guidelines&#xD;
&#xD;
          -  allergies to one of the plant species included in the vaginal test,&#xD;
&#xD;
          -  diabetes mellitus,&#xD;
&#xD;
          -  pregnancy,&#xD;
&#xD;
          -  lactation,&#xD;
&#xD;
          -  immunodeficiency disorder,&#xD;
&#xD;
          -  severe chronic illness,&#xD;
&#xD;
          -  previous radiotherapy, chemotherapy and biological therapy&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fahir Becic, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Universiyt of Sarajevo Faculty of Pharmacy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kemal Duric</name>
      <address>
        <city>Sarajevo</city>
        <state>Canton Sarajevo</state>
        <zip>71000</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bosnia and Herzegovina</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>August 31, 2020</study_first_submitted>
  <study_first_submitted_qc>September 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 22, 2020</study_first_posted>
  <last_update_submitted>September 17, 2020</last_update_submitted>
  <last_update_submitted_qc>September 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sarajevo</investigator_affiliation>
    <investigator_full_name>Kemal DuriÄ‡, PhD</investigator_full_name>
    <investigator_title>Kemal Duric PhD, Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaginosis, Bacterial</mesh_term>
    <mesh_term>Vaginitis</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tea Tree Oil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

